Rheumatic immune-related adverse events associated with immune checkpoint inhibitors compared with placebo in oncologic patients: a systemic review and meta-analysis

OBJECTIVE: We aim to characterize the incidence and relative risk of rheumatic and systemic immune-related adverse effects (irAEs) among immune checkpoint inhibitor (ICI) therapy compared with those after placebo treatment. METHODS: Randomized clinical trial studies with placebo control with the fol...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shuo, Zhou, Ziyue, Wang, Li, Li, Mengtao, Zhang, Fengchun, Zeng, Xiaofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887685/
https://www.ncbi.nlm.nih.gov/pubmed/33633822
http://dx.doi.org/10.1177/2040622320976996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887685/
https://www.ncbi.nlm.nih.gov/pubmed/33633822
http://dx.doi.org/10.1177/2040622320976996

Ejemplares similares